Neuronetics Short Term Debt vs Long Term Debt Total Analysis

STIM Stock

USD 2.61 0.09 3.57%

Neuronetics financial indicator trend analysis is infinitely more than just investigating Neuronetics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neuronetics is a good investment. Please check the relationship between Neuronetics Short Term Debt and its Long Term Debt Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Short Term Debt vs Long Term Debt Total

Short Term Debt vs Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neuronetics Short Term Debt account and Long Term Debt Total. At this time, the significance of the direction appears to have very week relationship.

The correlation between Neuronetics' Short Term Debt and Long Term Debt Total is 0.24. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of Neuronetics, assuming nothing else is changed. The correlation between historical values of Neuronetics' Short Term Debt and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Neuronetics are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Short Term Debt i.e., Neuronetics' Short Term Debt and Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Short Term Debt

Long Term Debt Total

Most indicators from Neuronetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neuronetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.As of the 18th of May 2024, Selling General Administrative is likely to drop to about 19.4 M. In addition to that, Issuance Of Capital Stock is likely to drop to 0.00

	2023	2024 (projected)
Depreciation And Amortization	2.0M	1.8M
Interest Income	4.2M	3.3M

Depreciation And Amortization Interest Income

Neuronetics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets
Total Assets		0.81	0.74	0.59	0.97	0.61	0.97	0.81	0.86	-0.73	-0.82	0.88	0.96	0.85	0.85	0.5	0.7	0.96	0.74	0.94	0.92	0.61	-0.94	0.96	0.8	0.74
Short Long Term Debt Total	0.81		0.81	0.51	0.78	0.45	0.81	0.8	0.58	-0.26	-0.9	0.85	0.65	0.86	0.81	0.23	0.93	0.66	0.93	0.89	0.9	0.64	-0.74	0.89	0.86	0.88
Other Current Liab	0.74	0.81		0.85	0.69	0.29	0.72	0.79	0.47	-0.27	-0.85	0.56	0.58	0.74	0.7	0.06	0.59	0.59	0.93	0.81	0.84	0.41	-0.68	0.8	0.92	0.63
Total Current Liabilities	0.59	0.51	0.85		0.61	0.22	0.61	0.76	0.42	-0.32	-0.64	0.43	0.5	0.58	0.52	0.0	0.18	0.5	0.66	0.64	0.7	0.11	-0.65	0.64	0.68	0.37
Total Stockholder Equity	0.97	0.78	0.69	0.61		0.6	1.0	0.82	0.85	-0.72	-0.81	0.88	0.95	0.81	0.79	0.41	0.65	0.95	0.7	0.94	0.91	0.63	-0.99	0.96	0.73	0.72
Other Liab	0.61	0.45	0.29	0.22	0.6		0.58	0.37	0.86	-0.61	-0.35	0.73	0.69	0.34	0.32	0.21	0.46	0.69	0.21	0.47	0.44	0.8	-0.57	0.51	0.24	0.34
Net Tangible Assets	0.97	0.81	0.72	0.61	1.0	0.58		0.83	0.83	-0.67	-0.85	0.9	0.93	0.83	0.8	0.38	0.69	0.94	0.73	0.96	0.92	0.64	-0.98	0.96	0.75	0.77
Property Plant And Equipment Net	0.81	0.8	0.79	0.76	0.82	0.37	0.83		0.64	-0.37	-0.85	0.75	0.65	0.94	0.89	0.44	0.57	0.67	0.79	0.87	0.96	0.38	-0.83	0.88	0.85	0.71
Current Deferred Revenue	0.86	0.58	0.47	0.42	0.85	0.86	0.83	0.64		-0.76	-0.62	0.82	0.91	0.64	0.65	0.52	0.5	0.91	0.39	0.75	0.7	0.72	-0.81	0.74	0.51	0.56
Net Debt	-0.73	-0.26	-0.27	-0.32	-0.72	-0.61	-0.67	-0.37	-0.76		0.23	-0.57	-0.86	-0.38	-0.41	-0.48	-0.2	-0.86	-0.17	-0.47	-0.47	-0.37	0.71	-0.61	-0.29	-0.13
Retained Earnings	-0.82	-0.9	-0.85	-0.64	-0.81	-0.35	-0.85	-0.85	-0.62	0.23		-0.74	-0.67	-0.87	-0.83	-0.26	-0.76	-0.68	-0.88	-0.96	-0.91	-0.57	0.77	-0.85	-0.89	-0.92
Accounts Payable	0.88	0.85	0.56	0.43	0.88	0.73	0.9	0.75	0.82	-0.57	-0.74		0.85	0.77	0.72	0.37	0.8	0.85	0.65	0.86	0.83	0.69	-0.85	0.87	0.6	0.8
Cash	0.96	0.65	0.58	0.5	0.95	0.69	0.93	0.65	0.91	-0.86	-0.67	0.85		0.68	0.68	0.46	0.57	1.0	0.55	0.84	0.78	0.61	-0.91	0.86	0.61	0.6
Non Current Assets Total	0.85	0.86	0.74	0.58	0.81	0.34	0.83	0.94	0.64	-0.38	-0.87	0.77	0.68		0.99	0.61	0.72	0.69	0.82	0.89	0.96	0.43	-0.78	0.9	0.9	0.79
Non Currrent Assets Other	0.85	0.81	0.7	0.52	0.79	0.32	0.8	0.89	0.65	-0.41	-0.83	0.72	0.68	0.99		0.71	0.69	0.7	0.76	0.86	0.92	0.41	-0.74	0.87	0.89	0.75
Other Assets	0.5	0.23	0.06	0.0	0.41	0.21	0.38	0.44	0.52	-0.48	-0.26	0.37	0.46	0.61	0.71		0.24	0.47	0.11	0.36	0.43	0.08	-0.34	0.41	0.38	0.28
Long Term Debt	0.7	0.93	0.59	0.18	0.65	0.46	0.69	0.57	0.5	-0.2	-0.76	0.8	0.57	0.72	0.69	0.24		0.57	0.8	0.76	0.74	0.71	-0.58	0.76	0.7	0.85
Cash And Short Term Investments	0.96	0.66	0.59	0.5	0.95	0.69	0.94	0.67	0.91	-0.86	-0.68	0.85	1.0	0.69	0.7	0.47	0.57		0.55	0.84	0.78	0.62	-0.91	0.87	0.62	0.61
Net Receivables	0.74	0.93	0.93	0.66	0.7	0.21	0.73	0.79	0.39	-0.17	-0.88	0.65	0.55	0.82	0.76	0.11	0.8	0.55		0.84	0.88	0.45	-0.68	0.85	0.93	0.77
Common Stock Total Equity	0.94	0.89	0.81	0.64	0.94	0.47	0.96	0.87	0.75	-0.47	-0.96	0.86	0.84	0.89	0.86	0.36	0.76	0.84	0.84		0.95	0.61	-0.91	0.94	0.86	0.89
Common Stock Shares Outstanding	0.92	0.9	0.84	0.7	0.91	0.44	0.92	0.96	0.7	-0.47	-0.91	0.83	0.78	0.96	0.92	0.43	0.74	0.78	0.88	0.95		0.54	-0.9	0.97	0.91	0.79
Long Term Debt Total	0.61	0.64	0.41	0.11	0.63	0.8	0.64	0.38	0.72	-0.37	-0.57	0.69	0.61	0.43	0.41	0.08	0.71	0.62	0.45	0.61	0.54		-0.6	0.6	0.43	0.56
Non Current Liabilities Total	-0.94	-0.74	-0.68	-0.65	-0.99	-0.57	-0.98	-0.83	-0.81	0.71	0.77	-0.85	-0.91	-0.78	-0.74	-0.34	-0.58	-0.91	-0.68	-0.91	-0.9	-0.6		-0.94	-0.69	-0.66
Capital Surpluse	0.96	0.89	0.8	0.64	0.96	0.51	0.96	0.88	0.74	-0.61	-0.85	0.87	0.86	0.9	0.87	0.41	0.76	0.87	0.85	0.94	0.97	0.6	-0.94		0.86	0.75
Inventory	0.8	0.86	0.92	0.68	0.73	0.24	0.75	0.85	0.51	-0.29	-0.89	0.6	0.61	0.9	0.89	0.38	0.7	0.62	0.93	0.86	0.91	0.43	-0.69	0.86		0.72
Other Current Assets	0.74	0.88	0.63	0.37	0.72	0.34	0.77	0.71	0.56	-0.13	-0.92	0.8	0.6	0.79	0.75	0.28	0.85	0.61	0.77	0.89	0.79	0.56	-0.66	0.75	0.72

Click cells to compare fundamentals

Neuronetics Account Relationship Matchups

Neuronetics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	100.2M	78.7M	141.2M	116.9M	115.8M	100.9M
Short Long Term Debt Total	34.3M	38.3M	39.5M	39.7M	62.5M	40.5M
Other Current Liab	9.0M	7.3M	8.2M	14.8M	12.6M	10.1M
Total Current Liabilities	27.7M	13.7M	15.7M	33.2M	19.8M	20.5M
Total Stockholder Equity	47.9M	25.5M	85.2M	57.1M	34.2M	35.9M
Other Liab	2.1M	1.7M	1.5M	829K	746.1K	1.2M
Net Tangible Assets	46.7M	25.5M	85.2M	57.1M	65.6M	68.9M
Property Plant And Equipment Net	4.9M	4.1M	5.1M	5.3M	4.8M	3.9M
Current Deferred Revenue	2.2M	2.0M	2.5M	2.0M	1.6M	2.2M
Net Debt	(41.4M)	(10.6M)	(54.6M)	(30.6M)	2.8M	2.9M
Retained Earnings	(250.1M)	(277.5M)	(308.7M)	(345.9M)	(376.1M)	(394.9M)
Accounts Payable	4.6M	3.7M	4.3M	2.4M	4.8M	3.8M
Cash	75.7M	49.0M	94.1M	70.3M	59.7M	68.7M
Non Current Assets Total	11.7M	13.6M	25.9M	18.1M	22.0M	13.4M
Non Currrent Assets Other	5.1M	7.2M	19.1M	11.6M	12.8M	7.9M
Other Assets	5.6M	12.9M	167.1M	9.2M	1.0	0.95
Long Term Debt	19.9M	34.6M	35.3M	22.8M	59.3M	34.0M
Cash And Short Term Investments	76.6M	50.8M	96.3M	71.9M	60.6M	69.7M
Net Receivables	6.6M	7.2M	7.8M	13.8M	17.8M	9.2M
Common Stock Total Equity	177K	186K	191K	273K	314.0K	329.6K
Common Stock Shares Outstanding	18.4M	18.8M	25.5M	26.9M	28.7M	17.5M
Long Term Debt Total	30.4M	19.9M	34.6M	22.8M	26.3M	28.2M
Liabilities And Stockholders Equity	100.2M	78.7M	141.2M	116.9M	115.8M	100.9M
Non Current Liabilities Total	24.6M	39.5M	40.3M	26.6M	61.8M	63.4M
Capital Surpluse	291.9M	297.8M	302.8M	402.7M	463.1M	238.9M
Inventory	2.8M	3.7M	6.6M	8.9M	8.1M	5.0M
Other Current Assets	2.5M	3.3M	4.6M	2.2M	7.3M	7.6M
Other Stockholder Equity	297.8M	302.8M	393.6M	402.7M	410.0M	274.4M
Total Liab	52.3M	53.2M	56.0M	59.8M	81.6M	78.2M
Property Plant And Equipment Gross	4.9M	4.1M	5.1M	5.3M	7.6M	4.3M
Total Current Assets	88.5M	65.0M	115.3M	98.8M	93.8M	87.4M
Common Stock	186K	191K	264K	273K	291K	190.6K
Property Plant Equipment	4.9M	730K	5.1M	2.0M	2.3M	2.7M
Net Invested Capital	79M	60.1M	120.5M	93.0M	93.5M	60.4M
Net Working Capital	60.8M	51.3M	99.6M	65.6M	74.0M	75.0M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Neuronetics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:

How To Invest In Neuronetics

Details

Is Neuronetics Stock a good investment?

Details

What is Neuronetics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Neuronetics Stock analysis

When running Neuronetics' price analysis, check to measure Neuronetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuronetics is operating at the current time. Most of Neuronetics' value examination focuses on studying past and present price action to predict the probability of Neuronetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuronetics' price. Additionally, you may evaluate how the addition of Neuronetics to your portfolios can decrease your overall portfolio volatility.

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Stocks Directory Find actively traded stocks across global markets
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is Neuronetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.94)

Revenue Per Share

2.523

Quarterly Revenue Growth

0.121

Return On Assets

(0.15)

Return On Equity

(0.72)

The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neuronetics Short Term Debt vs Long Term Debt Total Analysis

Short Term Debt vs Long Term Debt Total

Short Term Debt vs Long Term Debt Total Correlation Analysis

Correlation Coefficient

Short Term Debt

Long Term Debt Total

Neuronetics fundamental ratios Correlations

Neuronetics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neuronetics fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Neuronetics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Non Currrent Assets Other	+ 0.99	Non Current Assets Total
Total Stockholder Equity	+ 0.97	Total Assets
Net Tangible Assets	+ 0.97	Total Assets
Capital Surpluse	+ 0.97	Common Stock Shares Outstanding

Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Non Current Liabilities Total	- 0.98	Net Tangible Assets
Common Stock Total Equity	- 0.96	Retained Earnings
Capital Surpluse	- 0.94	Non Current Liabilities Total
Non Current Liabilities Total	- 0.94	Total Assets
Other Current Assets	- 0.92	Retained Earnings